NO309608B1 - DNA-sekvens som koder for syntetiske tRNA samt fremgangsmåte for fremstilling av tRNA - Google Patents
DNA-sekvens som koder for syntetiske tRNA samt fremgangsmåte for fremstilling av tRNA Download PDFInfo
- Publication number
- NO309608B1 NO309608B1 NO940670A NO940670A NO309608B1 NO 309608 B1 NO309608 B1 NO 309608B1 NO 940670 A NO940670 A NO 940670A NO 940670 A NO940670 A NO 940670A NO 309608 B1 NO309608 B1 NO 309608B1
- Authority
- NO
- Norway
- Prior art keywords
- trna
- aaa
- gene
- coli
- ala
- Prior art date
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 108020004566 Transfer RNA Proteins 0.000 claims abstract description 181
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 58
- 241000588724 Escherichia coli Species 0.000 claims abstract description 41
- 150000001413 amino acids Chemical class 0.000 claims description 29
- 108020005098 Anticodon Proteins 0.000 claims description 24
- 239000013612 plasmid Substances 0.000 claims description 20
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 claims description 14
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 108020004414 DNA Proteins 0.000 claims description 9
- 101710137500 T7 RNA polymerase Proteins 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 238000012163 sequencing technique Methods 0.000 claims description 5
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 229960000723 ampicillin Drugs 0.000 claims description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 230000009466 transformation Effects 0.000 claims description 2
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 101100281686 Mus musculus Fstl1 gene Proteins 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 210000003705 ribosome Anatomy 0.000 abstract description 58
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 54
- 238000003786 synthesis reaction Methods 0.000 abstract description 54
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 34
- 229920001184 polypeptide Polymers 0.000 abstract description 14
- 230000001419 dependent effect Effects 0.000 abstract description 11
- 238000000338 in vitro Methods 0.000 abstract description 7
- 239000002253 acid Substances 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 description 53
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 50
- 230000027455 binding Effects 0.000 description 34
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 32
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 31
- 235000001014 amino acid Nutrition 0.000 description 31
- 108010054442 polyalanine Proteins 0.000 description 26
- 229960003276 erythromycin Drugs 0.000 description 25
- 108010039177 polyphenylalanine Proteins 0.000 description 22
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 18
- 239000003999 initiator Substances 0.000 description 18
- 230000006229 amino acid addition Effects 0.000 description 17
- 229950010131 puromycin Drugs 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- 108010077051 polycysteine Proteins 0.000 description 15
- 230000014616 translation Effects 0.000 description 15
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 14
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 14
- 102000003960 Ligases Human genes 0.000 description 14
- 108090000364 Ligases Proteins 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 238000013519 translation Methods 0.000 description 14
- 108010049395 Prokaryotic Initiation Factor-2 Proteins 0.000 description 13
- 235000004279 alanine Nutrition 0.000 description 13
- 108010000222 polyserine Proteins 0.000 description 13
- 238000010348 incorporation Methods 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 238000006862 quantum yield reaction Methods 0.000 description 11
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 10
- 235000018417 cysteine Nutrition 0.000 description 10
- 230000000977 initiatory effect Effects 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 241000209140 Triticum Species 0.000 description 9
- 235000021307 Triticum Nutrition 0.000 description 9
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 9
- 108020004705 Codon Proteins 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000000295 emission spectrum Methods 0.000 description 8
- 230000002255 enzymatic effect Effects 0.000 description 8
- 238000000198 fluorescence anisotropy Methods 0.000 description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 229950009641 sparsomycin Drugs 0.000 description 7
- XKLZIVIOZDNKEQ-CLQLPEFOSA-N sparsomycin Chemical compound CSC[S@](=O)C[C@H](CO)NC(=O)\C=C\C1=C(C)NC(=O)NC1=O XKLZIVIOZDNKEQ-CLQLPEFOSA-N 0.000 description 7
- XKLZIVIOZDNKEQ-UHFFFAOYSA-N sparsomycin Natural products CSCS(=O)CC(CO)NC(=O)C=CC1=C(C)NC(=O)NC1=O XKLZIVIOZDNKEQ-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 108010039918 Polylysine Proteins 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 229920000656 polylysine Polymers 0.000 description 5
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 108091034057 RNA (poly(A)) Proteins 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000010647 peptide synthesis reaction Methods 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 210000004708 ribosome subunit Anatomy 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000276498 Pollachius virens Species 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 229940063673 spermidine Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- COLNVLDHVKWLRT-BCBQVJQISA-N (2S)-2-amino-3-phenyl(214C)propanoic acid Chemical compound N[14C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-BCBQVJQISA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical class C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
- 235000013928 guanylic acid Nutrition 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- AKYHKWQPZHDOBW-UHFFFAOYSA-N (5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol Chemical compound OS(O)(=O)=O.C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 AKYHKWQPZHDOBW-UHFFFAOYSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- YGIABALXNBVHBX-UHFFFAOYSA-N 1-[4-[7-(diethylamino)-4-methyl-2-oxochromen-3-yl]phenyl]pyrrole-2,5-dione Chemical compound O=C1OC2=CC(N(CC)CC)=CC=C2C(C)=C1C(C=C1)=CC=C1N1C(=O)C=CC1=O YGIABALXNBVHBX-UHFFFAOYSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- 241000023308 Acca Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 102000004403 Cysteine-tRNA ligases Human genes 0.000 description 1
- 108090000918 Cysteine-tRNA ligases Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 239000001576 FEMA 2977 Substances 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 229920002352 Peptidyl-tRNA Polymers 0.000 description 1
- 108091028733 RNTP Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001294 alanine derivatives Chemical class 0.000 description 1
- 150000005303 alkyl halide derivatives Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPTBLXKRQACLCR-XVFCMESISA-N dihydrouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)CC1 ZPTBLXKRQACLCR-XVFCMESISA-N 0.000 description 1
- VCSZKSHWUBFOOE-UHFFFAOYSA-N dioxidanium;sulfate Chemical compound O.O.OS(O)(=O)=O VCSZKSHWUBFOOE-UHFFFAOYSA-N 0.000 description 1
- VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000001069 large ribosome subunit Anatomy 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 125000001151 peptidyl group Chemical group 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960003110 quinine sulfate Drugs 0.000 description 1
- RONWGALEIBILOG-VMJVVOMYSA-N quinine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 RONWGALEIBILOG-VMJVVOMYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 229940081330 tena Drugs 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Glass Compositions (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75326691A | 1991-08-30 | 1991-08-30 | |
| PCT/US1992/007065 WO1993005062A1 (en) | 1991-08-30 | 1992-08-21 | SYNTHETIC tRNAs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO940670L NO940670L (no) | 1994-02-25 |
| NO940670D0 NO940670D0 (no) | 1994-02-25 |
| NO309608B1 true NO309608B1 (no) | 2001-02-26 |
Family
ID=25029910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940670A NO309608B1 (no) | 1991-08-30 | 1994-02-25 | DNA-sekvens som koder for syntetiske tRNA samt fremgangsmåte for fremstilling av tRNA |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5358862A (de) |
| EP (1) | EP0601117B1 (de) |
| JP (1) | JP3439763B2 (de) |
| KR (1) | KR100244625B1 (de) |
| CN (1) | CN1056188C (de) |
| AT (1) | ATE187492T1 (de) |
| AU (1) | AU661338B2 (de) |
| CA (1) | CA2115050C (de) |
| DE (1) | DE69230404T2 (de) |
| DK (1) | DK0601117T3 (de) |
| ES (1) | ES2141111T3 (de) |
| FI (1) | FI111464B (de) |
| GR (1) | GR3032899T3 (de) |
| IL (1) | IL102924A (de) |
| NO (1) | NO309608B1 (de) |
| NZ (1) | NZ244124A (de) |
| RU (1) | RU2111250C1 (de) |
| WO (1) | WO1993005062A1 (de) |
| ZA (1) | ZA926518B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798240A (en) * | 1994-09-13 | 1998-08-25 | Cubist Pharmaceuticals, Inc. | Recombinant mycobacterial methionyl-tRNA synthetase genes and methods of use therefore |
| EP0785257A1 (de) * | 1996-01-19 | 1997-07-23 | Smithkline Beecham Plc | Cysteinyl-tRNA Synthetase aus Staphylococcus aureus |
| US6461815B1 (en) * | 1998-05-22 | 2002-10-08 | North Carolina State University | Antibacterial agents and methods of screening for the same |
| CN101189343B (zh) * | 2004-08-23 | 2011-11-16 | 阿尔尼拉姆药物公司 | 多rna聚合酶ⅲ启动子表达构建体 |
| US7799542B2 (en) * | 2006-06-29 | 2010-09-21 | The Invention Science Fund I, Llc | Apparatus for arbitrary peptide synthesis |
| US7879975B2 (en) * | 2006-06-29 | 2011-02-01 | The Invention Science Fund I, Llc | Methods for arbitrary peptide synthesis |
| US7910695B2 (en) * | 2006-06-29 | 2011-03-22 | The Invention Science Fund I, Llc | Methods for arbitrary peptide synthesis |
| US7923533B2 (en) * | 2006-06-29 | 2011-04-12 | The Invention Science Fund I, Llc | Methods for arbitrary peptide synthesis |
| US7598040B2 (en) * | 2006-11-22 | 2009-10-06 | Trana Discovery, Inc. | Compositions and methods for the identification of inhibitors of protein synthesis |
| EP2197455A4 (de) * | 2007-09-14 | 2010-10-20 | Univ North Carolina State | Zusammensetzungen und verfahren zur identifizierung von inhibitoren von retroviralen infektionen |
| EP2342339A4 (de) * | 2008-09-29 | 2012-06-06 | Trana Discovery Inc | Screening-verfahren zur identifizierung spezifischer staphylococcus aureus-inhibitoren |
| CN117070512B (zh) * | 2023-10-16 | 2024-04-26 | 吉林凯莱英医药化学有限公司 | tRNA及其生物合成方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3317983B2 (ja) * | 1991-08-20 | 2002-08-26 | 日本酸素株式会社 | 非天然型アミノ酸組み込み蛋白質とその製造法及び試薬キット |
-
1992
- 1992-07-14 US US07/914,212 patent/US5358862A/en not_active Expired - Lifetime
- 1992-08-21 WO PCT/US1992/007065 patent/WO1993005062A1/en active IP Right Grant
- 1992-08-21 AT AT92919932T patent/ATE187492T1/de not_active IP Right Cessation
- 1992-08-21 DK DK92919932T patent/DK0601117T3/da active
- 1992-08-21 KR KR1019940700582A patent/KR100244625B1/ko not_active IP Right Cessation
- 1992-08-21 JP JP50522593A patent/JP3439763B2/ja not_active Expired - Fee Related
- 1992-08-21 DE DE69230404T patent/DE69230404T2/de not_active Expired - Fee Related
- 1992-08-21 CA CA002115050A patent/CA2115050C/en not_active Expired - Fee Related
- 1992-08-21 AU AU25890/92A patent/AU661338B2/en not_active Ceased
- 1992-08-21 ES ES92919932T patent/ES2141111T3/es not_active Expired - Lifetime
- 1992-08-21 RU RU94020404A patent/RU2111250C1/ru not_active IP Right Cessation
- 1992-08-21 EP EP92919932A patent/EP0601117B1/de not_active Expired - Lifetime
- 1992-08-24 IL IL10292492A patent/IL102924A/xx not_active IP Right Cessation
- 1992-08-28 ZA ZA926518A patent/ZA926518B/xx unknown
- 1992-08-28 NZ NZ244124A patent/NZ244124A/en not_active IP Right Cessation
- 1992-08-29 CN CN92110198A patent/CN1056188C/zh not_active Expired - Fee Related
-
1994
- 1994-02-25 NO NO940670A patent/NO309608B1/no unknown
- 1994-02-25 FI FI940912A patent/FI111464B/fi not_active IP Right Cessation
-
2000
- 2000-03-08 GR GR20000400594T patent/GR3032899T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA926518B (en) | 1993-04-28 |
| ATE187492T1 (de) | 1999-12-15 |
| DK0601117T3 (da) | 2000-04-10 |
| NO940670L (no) | 1994-02-25 |
| DE69230404T2 (de) | 2000-09-21 |
| CA2115050C (en) | 2003-02-04 |
| IL102924A0 (en) | 1993-01-31 |
| CA2115050A1 (en) | 1993-03-18 |
| EP0601117A4 (de) | 1995-02-08 |
| EP0601117A1 (de) | 1994-06-15 |
| EP0601117B1 (de) | 1999-12-08 |
| AU2589092A (en) | 1993-04-05 |
| CN1086261A (zh) | 1994-05-04 |
| GR3032899T3 (en) | 2000-07-31 |
| CN1056188C (zh) | 2000-09-06 |
| JPH07503125A (ja) | 1995-04-06 |
| AU661338B2 (en) | 1995-07-20 |
| ES2141111T3 (es) | 2000-03-16 |
| NZ244124A (en) | 1994-04-27 |
| FI940912A (fi) | 1994-02-25 |
| IL102924A (en) | 2000-06-01 |
| US5358862A (en) | 1994-10-25 |
| WO1993005062A1 (en) | 1993-03-18 |
| RU2111250C1 (ru) | 1998-05-20 |
| DE69230404D1 (de) | 2000-01-13 |
| FI111464B (fi) | 2003-07-31 |
| NO940670D0 (no) | 1994-02-25 |
| FI940912A0 (fi) | 1994-02-25 |
| KR100244625B1 (ko) | 2000-02-15 |
| JP3439763B2 (ja) | 2003-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO309608B1 (no) | DNA-sekvens som koder for syntetiske tRNA samt fremgangsmåte for fremstilling av tRNA | |
| EP2995683B1 (de) | Verfahren zur herstellung einer peptidbibliothek, peptidbibliothek und screeningverfahren | |
| US20150099271A1 (en) | Fluorescent proteins, split fluorescent proteins, and their uses | |
| Kipper et al. | Ribosomal intersubunit bridge B2a is involved in factor-dependent translation initiation and translational processivity | |
| US20100021941A1 (en) | Methods of identifying modulators of ubiquitin ligases | |
| Singh et al. | Recycling of ribosomal complexes stalled at the step of elongation in Escherichia coli | |
| US20100138944A1 (en) | Methods of Reducing Repeat-Induced Silencing of Transgene Expression and Improved Fluorescent Biosensors | |
| US20060134748A1 (en) | Orthogonal suppressor tRNAs and aminoacyl-tRNA synthetases and uses thereof | |
| US11932846B2 (en) | Chloramphenicol resistant split protein and uses thereof | |
| Guzzo et al. | Systematic analysis of fusion and affinity tags using human aspartyl-tRNA synthetase expressed in E. coli | |
| Picking et al. | The use of synthetic tRNAs as probes for examining nascent peptides on Escherichia coli ribosomes | |
| Močibob et al. | Seryl-tRNA synthetases in translation and beyond | |
| Bailey et al. | The Arabidopsis NOT4A E3 ligase coordinates PGR3 expression to regulate chloroplast protein translation | |
| Picking et al. | A synthetic alanyl-initiator tRNA with initiator tRNA properties as determined by flourescence measurements: comparison to a synthetic alanyl-elongator tRNA | |
| Zhou | Profiling Substrate Proteins of Ring and RBR type E3 ligases by Orthogonal Ubiquitin Transfer and the Development of a Peptide Activator Targeting HECT-type E3 ligase | |
| KR20090077243A (ko) | 시험관 전사법으로 준비된 ｔＲＮＡ로부터 제조된 표지자를이용한 시험관 번역법으로 생산되는 단백질의 선택적표지방법 | |
| Londei | Translation | |
| Liu | Mechanistic Studies of the Elongation Cycle of Protein Synthesis | |
| US20120022232A1 (en) | Cells for increased protein expression comprising one or more release factors and methods of use | |
| Leopold | HP1 protein Chp2 selectively recruits nucleosome remodeler through non-canonical interaction | |
| JP2006508672A (ja) | 最適化タンパク質合成 | |
| Chen | Characterization of Prolyl-tRNA Synthetase, YbaK, and ProXp-ala Editing Mechanism | |
| Chisty | PcrA function in plasmid replication | |
| High et al. | Characteristics of the new wheat germ cell-free translation system Wheat embryos E. coli cells Rabbit reticulocytes Productivity (mg per ml) 10 6 pug order Folding Co-translation Post-translation Co-translation | |
| Hadjivassiliou | Mechanisms of pre-mRNA splicing in yeast |